Collecting data on thyroid, parathyroid, and adrenal diseases
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
This study is collecting health information from people with thyroid, parathyroid, and adrenal diseases to see how these conditions affect them over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT03050762 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather comprehensive data on patients with thyroid, parathyroid, and adrenal diseases. Participants will have their medical records reviewed and information entered into a research database at MD Anderson. The study will track the current or suspected illnesses, surgeries, and recoveries of participants over a period of up to 15 years, with follow-up phone calls starting 2-3 years after diagnosis or treatment. This long-term data collection will help researchers better understand these endocrine diseases.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed or suspected of having endocrine diseases who are being seen at MD Anderson.
Not a fit: Patients without a diagnosis or suspicion of endocrine disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of endocrine diseases, potentially leading to improved patient outcomes and treatment strategies.
How similar studies have performed: Other studies focusing on data collection for chronic diseases have shown success in improving patient care and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic. 2. In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease. Exclusion Criteria: N/A
Where this trial is running
Houston, Texas
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Nancy D. Perrier, MD — M.D. Anderson Cancer Center
- Study coordinator: Nancy D. Perrier, MD
- Email: NPerrier@mdanderson.org
- Phone: 713-792-6940
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.